[Ureteral lesions in radical hysterectomy with pelvic lymph node excision].
[Radical lymph node excision in endometrial carcinoma: the restriction of pelvic irradiation to node-positive cases?].
Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.
Touijer KA, Sjoberg DD, Benfante N, Laudone VP, Ehdaie B, Eastham JA, Scardino PT, Vickers A.
Eur Urol Oncol. 2021 Aug;4(4):532-539. doi: 10.1016/j.euo.2021.03.006. Epub 2021 Apr 15.
Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus After Robot-Assisted Laparoscopic Radical Cystectomy.
Wang S, Zhang D, Bai Y, Liu F, Qi X, Xie L.
J Laparoendosc Adv Surg Tech A. 2023 Aug;33(8):776-781. doi: 10.1089/lap.2023.0118. Epub 2023 Jun 1.
Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis.
Hinojosa-Gonzalez DE, Nolazco JI, Saffati G, Kronstedt S, Jones JA, Kadmon D, Badal J, Slawin JR.
Eur Urol Focus. 2024 Mar;10(2):234-241. doi: 10.1016/j.euf.2024.01.002. Epub 2024 Jan 18.
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.
Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.
Pelvic lymph node dissection in high-risk prostate cancer.
Haiquel L, Cathelineau X, Sanchez-Salas R, Macek P, Secin F.
Int Braz J Urol. 2022 Jan-Feb;48(1):54-66. doi: 10.1590/S1677-5538.IBJU.2020.1063.
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, Cordeiro MD, Sarkis AS, Faraj SF, Mitre AI, Srougi M, Nahas WC.
Eur Urol. 2021 May;79(5):595-604. doi: 10.1016/j.eururo.2020.11.040. Epub 2020 Dec 5.
Clinical significance of limited and extended pelvic lymph node dissection during robot-assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.
Hori S, Nakai Y, Tachibana A, Omori C, Nishimura N, Inoue K, Tomizawa M, Shimizu T, Morizawa Y, Gotoh D, Miyake M, Torimoto K, Yoneda T, Fujimoto K, Tanaka N.
Int J Urol. 2023 Feb;30(2):168-175. doi: 10.1111/iju.15075. Epub 2022 Oct 28.
Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy.
Shimbo M, Endo F, Matsushita K, Hattori K.
Int J Urol. 2020 Oct;27(10):845-850. doi: 10.1111/iju.14306. Epub 2020 Jul 7.
Negative predictive value of PSMA PET scan for lymph node staging in patients undergoing robotic radical prostatectomy and pelvic lymph node dissection.
Adiyat KT, Pooleri GK, Cherian DT, Santhamma SGN, Ravichandran K, Sundaram S.
Int Urol Nephrol. 2023 Jun;55(6):1453-1457. doi: 10.1007/s11255-023-03595-0. Epub 2023 Apr 22.
Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
Van Eecke H, Devos G, Vansevenant B, Vander Stichele A, Devlies W, Berghen C, Everaerts W, De Meerleer G, Joniau S.
Int J Urol. 2023 Jan;30(1):92-99. doi: 10.1111/iju.15066. Epub 2022 Oct 28.
